Specifically, mice in the HFD+sema group were intraperitoneally injected with 30 mol/kg semaglutide (Novo Nordisk, Copenhagen, Denmark) once daily for another 12 weeks
After six months, high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels were significantly increased in the low-risk group, while the low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio decreased in the high-risk group, suggesting favorable lipid modulation
+ Can BPC-157 be combined with other recovery peptides
Supports antioxidant protection and reduces oxidative stress
Clinical trials are very regimented, and diabetes management in real life can look quite different
I only took advantage of three weeks total, though